GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES
GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES
Depository Receipt · US3984384087 · GRFS · A1J1E2 (XNAS)
Overview
8,82 USD
1,15 % 0,10 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 19:59

Current Prices from GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
GRFS
USD
06.06.2025 19:59
8,82 USD
8,72 USD
+1,15 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 6,27 % 22,16 % 3,76 % 20,82 % 17,44 % -55,94 %

Firmenprofil zu GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES Hinterlegungsschein

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring–to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

Investierte Fonds

Folgende Fonds haben in investiert: GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
58,85
Anteil (%)
0,14 %

Unternehmensdaten

Name GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES
Firma Grifols, S.A.
Symbol GRFS
Website https://www.grifols.com
Heimatbörse XNAS NASDAQ
WKN A1J1E2
ISIN US3984384087
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Jose Ignacio Abia Buenache
Marktkapitalisierung 6 Mrd.
Land Spanien
Währung USD
Mitarbeiter 23,8 T
Adresse Avinguda de la Generalitat, 152, 08174 Barcelona
IPO Datum 2011-06-02

Aktien-Splits

Datum Split
04.01.2016 2:1
11.12.2012 21:20
23.07.2012 1:2
01.12.2011 11:10

Ticker Symbole

Name Symbol
Frankfurt G0FB.F
NASDAQ GRFS

Weitere Aktien

Investoren die GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES die halten, haben auch folgende Aktien im Depot:
10X GENOMICS INC
10X GENOMICS INC Aktie
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
ALTISOURCE PORTFOLIO SOLUTIONS S.A. Aktie
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
AUTOMATIC DATA PROCESSING INC
AUTOMATIC DATA PROCESSING INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
DEGI EUROPA
DEGI EUROPA Fonds
HONEYWELL INTERNATIONAL INC
HONEYWELL INTERNATIONAL INC Aktie
INTEL CORP
INTEL CORP Aktie
LYXOR MSCI WORLD UCITS ETF - DIST
LYXOR MSCI WORLD UCITS ETF - DIST ETF
MICROSOFT CORP
MICROSOFT CORP Aktie
QIAGEN NV (alt)
QIAGEN NV (alt) Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025